Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominic M Walsh

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
Nature Chemical Biology|January 12, 2021
Laboratory evolution of a sortase enzyme that modifies amyloid-β proteinChristopher J Podracky, Chihui An, Alexandra DeSousa, et al.
The Journal of Biological Chemistry|September 25, 2010
Macroautophagy is not directly involved in the metabolism of amyloid precursor proteinBarry Boland, David A Smith, Declan Mooney, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 16, 2007
Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathwayGanesh M Shankar, Brenda L Bloodgood, Matthew Townsend, et al.
Neuron|February 25, 2003
The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's diseaseRonit Sharon, Ifat Bar-Joseph, Matthew P Frosch, et al.
Neurobiology of Aging|August 18, 2004
Species-specific immune response to immunization with human versus rodent A beta peptideTimothy J Seabrook, Jeanne K Bloom, Melitza Iglesias, et al.
Archives of Neurology|February 11, 2009
A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer diseaseWeiming Xia, Ting Yang, Ganesh Shankar, et al.
The FEBS Journal|January 30, 2009
A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptideDominic M Walsh, Eva Thulin, Aedín M Minogue, et al.
Biochemistry|October 14, 2009
An NSAID-like compound, FT-9, preferentially inhibits gamma-secretase cleavage of the amyloid precursor protein compared to its effect on amyloid precursor-like protein 1Carlo Sala Frigerio, Thomas L Kukar, Abdul Fauq, et al.
Molecular Neurodegeneration|August 7, 2025
A manifesto for Alzheimer's disease drug discovery in the era of disease-modifying therapiesHeike Hering, Thierry Bussiere, Chia-Chen Liu, et al.
Sensors (Basel, Switzerland)|November 23, 2016
Intracerebroventricular Administration of Amyloid β-protein Oligomers Selectively Increases Dorsal Hippocampal Dialysate Glutamate Levels in the Awake RatSean D O'Shea, Imelda M Smith, Olive M McCabe, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Nature Chemical Biology|January 12, 2021
Laboratory evolution of a sortase enzyme that modifies amyloid-β proteinChristopher J Podracky, Chihui An, Alexandra DeSousa, et al.
The Journal of Biological Chemistry|September 25, 2010
Macroautophagy is not directly involved in the metabolism of amyloid precursor proteinBarry Boland, David A Smith, Declan Mooney, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 16, 2007
Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathwayGanesh M Shankar, Brenda L Bloodgood, Matthew Townsend, et al.
Neuron|February 25, 2003
The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's diseaseRonit Sharon, Ifat Bar-Joseph, Matthew P Frosch, et al.
Neurobiology of Aging|August 18, 2004
Species-specific immune response to immunization with human versus rodent A beta peptideTimothy J Seabrook, Jeanne K Bloom, Melitza Iglesias, et al.
Archives of Neurology|February 11, 2009
A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer diseaseWeiming Xia, Ting Yang, Ganesh Shankar, et al.
The FEBS Journal|January 30, 2009
A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptideDominic M Walsh, Eva Thulin, Aedín M Minogue, et al.
Biochemistry|October 14, 2009
An NSAID-like compound, FT-9, preferentially inhibits gamma-secretase cleavage of the amyloid precursor protein compared to its effect on amyloid precursor-like protein 1Carlo Sala Frigerio, Thomas L Kukar, Abdul Fauq, et al.
Molecular Neurodegeneration|August 7, 2025
A manifesto for Alzheimer's disease drug discovery in the era of disease-modifying therapiesHeike Hering, Thierry Bussiere, Chia-Chen Liu, et al.
Sensors (Basel, Switzerland)|November 23, 2016
Intracerebroventricular Administration of Amyloid β-protein Oligomers Selectively Increases Dorsal Hippocampal Dialysate Glutamate Levels in the Awake RatSean D O'Shea, Imelda M Smith, Olive M McCabe, et al.
Pageof 13